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Abstract
Ca2/calmodulin-dependent protein kinases (CaMKs) are important intracellular mediators in the mediation of stimulus^
secretion coupling and excitation^contraction coupling in a wide variety of cell types. We attempted to identify and
characterize the functional roles of CaMK in mediating pancreatic enzyme secretion. Immunoprecipitation and
immunoblotting studies using a CaMKII or CaMKIV antibody showed that rat pancreatic acini expressed both CaMKII
and CaMKIV. Phosphotransferase activities of CaMKs were measured by a radioenzyme assay (REA) using autocamtide II,
peptide Q and myosin P-light chain as substrates. Although CaMKII and CaMKIV use autocamtide II as a substrate, peptide
Q is more efficiently phosphorylated by CaMKIV than by CaMKII. Intact acini were stimulated with cholecystokinin (CCK)-
8, carbachol (CCh) and the high-affinity CCK-A receptor agonist, CCK-OPE, and the cell lysates were used for REA. CCK-
8, CCh and CCK-OPE caused a concentration-dependent increase in CaMKs activities. When autocamtide II was used,
maximal increases were 1.5^1.8-fold over basal (20.2 þ 2.0 pmol/min/mg protein), with peaks occurring at 20 min after cell
stimulation. In separate studies that used peptide Q, CCK-8, CCh and CCK-OPE dose-dependently increased CaMKIV
activities. Maximal increases were 1.5^2.4-fold over basal (30.7 þ 3.2 pmol/min/mg protein) with peaks occurring at 20 min
after cell stimulation. Peak increases after cell stimulation induced by peptide Q were 1.8^2.8-fold higher than those induced
by autocamtide II. CCK-8, CCh and CCK-OPE also significantly increased phosphotransferase activities of myosin light
chain kinase (MLCK) substrate (basal : 4.4 þ 0.7 pmol/min/mg protein). However, maximal increases induced by MLCK
substrate were less than 10% of those occurring in peptide Q. Characteristics of the phosphotransferase activity were also
different between autocamtide II and peptide Q. When autocamtide II was used, elimination of medium Ca2 in either cell
lysates or intact cells resulted in a significant decrease in the activity, whereas it had no or little effect when peptide Q was
used. This suggests that Ca2 influx from the extracellular space is not fully required for CaMKIV activity and Ca2 is not a
prerequisite for phosphotransferase activity once CaMKIV is activated by either intracellular Ca2 release or intracellular
Ca2 oscillations. The specific CaMKII inhibitor KN-62 (50 WM) had no effect on the CaMKIV activity and pancreatic
enzyme secretion elicited by CCK-8, CCh and CCK-OPE. The specific MLCK inhibitor, ML-9 (10 WM), also did not inhibit
CCK-8-stimulated pancreatic amylase secretion. In contrast, wide spectrum CaMK inhibitors, K-252a (1 WM) and KT5926
(3 WM), significantly inhibited CaMKIV activities and enzyme secretion evoked by secretagogues. Thus, CaMKIV appears to
be an important intracellular mediator during stimulus^secretion coupling of rat pancreatic acinar cells. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Ca2 serves as a second messenger for the activa-
tion of a broad group of protein kinases that are
calmodulin (CaM)-dependent (reviewed in [1^3]).
CaM-dependent protein kinases (CaMKs) can phos-
phorylate a wide range of substrates and modulate
many cellular responses stimulated by an increasing
intracellular Ca2 concentration ([Ca2]i). CaMKs
are kept fairly inactive in unstimulated cells by the
presence of an autoinhibitory domain which can be
overcome by the binding of Ca2/CaM complex. The
conformation change in CaMKs by their binding to
Ca2/CaM allows them to phosphorylate the serine
and threonine residues of cellular substrates. In ad-
dition to myosin light chain kinase (MLCK), which
activates smooth muscle contraction, and phosphor-
ylase kinase, which activates glycogen breakdown,
¢ve other distinct CaMKs termed types I, II, III,
IV and V are presently known. These kinases phos-
phorylate serines and threonines in proteins and the
response of a target cell to an increase in [Ca2]i
depends on which CaMK-regulated target proteins
are present in the cell (reviewed in [4^7]).
CaMKI (molecular weight (MW): 37^42 kDa) was
¢rst identi¢ed and puri¢ed from bovine brain and
phosphorylates the synaptic vesicle protein, synapsin
I and II, and cAMP response element binding pro-
tein on the consensus sequence Hyd-XRRXS(T)-
XXX-Hyd, where Hyd represents a hydrophobic
amino acid. A Ca2/CaMK-dependent 52 kDa ki-
nase, which can activate and phosphorylate CaMKI,
has recently been puri¢ed and cloned (CaMKI ki-
nase). CaMKII is a well known multifunctional ki-
nase, which is widely distributed in many tissues es-
pecially in the brain. CaMKII functions in synthesis,
long-term potentiation, neurotransmission and for-
mation of spatial learning. CaMKII is composed of
several subunits ranging from 55 to 60 kDa in size
(K, L, LP, Q, N) and phosphorylates many substrates.
They include calcineurin, GABA-A receptor, inositol
1,4,5-trisphosphate receptor (IP3R), microtubule-as-
sociated protein 2, phospholipase A2, synapsins, tau,
tyrosine hydroxylase, and AMPA-type glutamate re-
ceptor on the consensus sequence RXXS(T). This
sequence is also found in CaMKII itself, thus allow-
ing an autophosphorylation at Thr-286 in the regu-
latory subunit upon binding Ca2/CaM, leading to
the activation of enzyme in a Ca2-independent man-
ner. CaMKIII has been puri¢ed from rabbit reticu-
locytes and rat pancreas (MW: 95^103 kDa). A
Ca2/CaM-dependent autophosphorylation on a ser-
ine residue(s) is required for activation of CaMKIII
and for the induction of a Ca2/CaM-independent
activity. This enzyme is distributed in many di¡erent
tissues and due to its restricted substrate speci¢city
(only elongation factor 2 (EF-2, MW: 100 kDa)), the
name EF-2 kinase rather than CaMKIII is gaining
wide acceptance. CaMKIV (Mr : 60 kDa), which was
initially named CaMK-Gr (granule), is a more re-
cently discovered monomeric kinase. It is mainly dis-
tributed in cerebellum, thymus and testis. In contrast
to other CaMKs, CaMKIV does not show stoichio-
metric autophosphorylation for its full activation
and it appears to require another kinase (68 kDa
CaMK kinase). CaMKIV has high sequence homol-
ogies with the catalytic and regulatory domains of
CaMKII and has an autoinhibitory domain that
can suppress kinase activity in the absence of Ca2/
CaM. Although CaMKII and CaMKIV share an
apparent similarity in consensus site for phosphory-
lation (RXXS(T)), sequences from the ribosomal S6
protein, CaMKIIQ (peptide Q), and Rab-1b protein
are more e⁄ciently phosphorylated by CaMKIV
than by CaMKII. CaMKV, a monomer of 41 kDa,
has several properties similar to CaMKI. The CaM-
KII inhibitor KN-62 also potently inhibits CaMKV
activity. These distinct CaMKs are di¡erentially dis-
tributed and function in di¡erent tissues (reviewed in
[4^7]).
The objective of this study was to identify and
characterize the functional roles of CaMK during
stimulus^secretion coupling of pancreatic acinar
cells. This was because our preliminary data showed
that the speci¢c CaMKII inhibitor KN-62 [8] did not
inhibit pancreatic enzyme secretion elicited by chol-
ecystokinin (CCK) analogues and carbachol (CCh),
even when the maximal doses of KN-62 were used
(50^100 WM) [9]. In control experiments, we showed
that KN-62 signi¢cantly and dose-dependently inhib-
BBAMCR 14638 22-5-00
H. Yoshida et al. / Biochimica et Biophysica Acta 1497 (2000) 155^167156
ited CCh-induced and Ca2-mediated gastric acid se-
cretion from rabbit parietal cells with an IC50 of 20
WM; KN-62 in turn did not a¡ect cAMP-mediated
acid secretion [10]. One report showed that the CaM
inhibitor (W-7, 100 WM) and KN-62 (10 WM) re-
duced rat pancreatic amylase secretion stimulated
by CCK, CCh, Ca2 ionophore, phorbol ester or
GTPQs, suggesting that CaM and CaMKII are in-
volved in Ca2-dependent pancreatic exocytosis
[11]. However, the inhibitory e¡ects of KN-62 were
only 10^20%, whereas W-7 caused a 75% reduction,
suggesting that other CaMKs may be involved in
Ca2-dependent secretion. Using autocamtide II, a
substrate for CaMKII, it has been reported that in
rat pancreatic acini CaMKII was rapidly activated
by a large increase in [Ca2]i stimulated by CCK,
CCh and bombesin [12]. Thus current evidence ad-
dressing the role of CaMKII in mediating pancreatic
enzyme secretion is con£icting, though a⁄nity chro-
matographical studies provided evidence that CaM
(19 kDa) is present and functions in stimulus^secre-
tion coupling of pancreatic acinar cells in various
species [13^17].
Three approaches were performed in this study:
(1) immunoprecipitation (IP) and immunoblotting
(IB) studies using di¡erent antibodies of CaMKs;
(2) radioenzyme assay (REA) using di¡erent sub-
strates for CaMKs; (3) functional studies using sev-
eral CaMK inhibitors. Results obtained suggest that
CaMKIV appears to be a major enzyme in mediating
Ca2-dependent pancreatic exocytosis.
2. Materials and methods
2.1. Materials
Chemicals were purchased from the following
sources: CCh, CCK-8 and soybean trypsin inhibitor
(SBTI) from Sigma (St. Louis, MO, USA); CCK-
OPE from Research Plus (Bayonne, NJ, USA);
fura-2/AM, W-7, KN-62, KN-93, K-252a, KT5926,
ML-9 and ophiobolin A from Calbiochem (San Die-
go, CA, USA); anti-CaMKII mouse monoclonal
antibody and anti-CaMKIV mouse monoclonal anti-
body (N-terminus) from Transduction Laboratories
(Lexington, KY, USA); anti-CaMKIV rabbit poly-
clonal antibody (C-terminus) and autocamtide II
from Upstate Biotechnology (Lake Placid, NY,
USA); peptide Q and MLCK substrate (myosin P-
light chain) from Biomol (Plymouth Meeting, PA,
USA). All chemicals were dissolved in either dimeth-
yl sulfoxide, ethanol, methanol, physiological salt so-
lution (PSS) or D2O, the ¢nal concentration being
0.01^0.1%; these concentrations of solvents did not
a¡ect the cell response.
2.2. Isolation of pancreatic acini and measurements of
amylase secretion and intracellular Ca2+
concentration
Isolated rat pancreatic acini were prepared by col-
lagenase digestion with pancreas obtained from male
Sprague^Dawley rats [18]. Acini were suspended in
PSS. The PSS contained 0.1% bovine serum albumin,
0.1 mg SBTI, and in mM: 137 NaCl, 4.7 KCl, 0.56
Mg2Cl2, 1.28 CaCl2, 1 NaH2PO4, 10 N-2-hydroxy-
ethylpiperazine-NP-ethanesulfonic acid (HEPES), Ea-
gles’ minimum essential amino acids neutralized with
NaOH, 2 L-glutamine and 5.5 D-glucose. The PSS
was adjusted to pH 7.35 and equilibrated with
100% O2. Isolated acini were preincubated for 40
min at 37‡C in 40 ml PSS, washed twice and resus-
pended in fresh PSS. Aliquots (2 ml) were distributed
into £asks, preincubated with or without inhibitors
for 10 min and further coincubated with secreta-
gogues for 60 min at 37‡C. The incubation was ter-
minated by centrifugation at 10 000 rpm for 50 s at
4‡C in a microfuge. The amylase released into the
supernatant and remaining in the pellet was assayed,
using a Procion yellow starch as a substrate [19].
Amylase secretion was expressed as a percentage of
the total content in each sample. Measurement of
[Ca2]i was performed as described previously [20].
Brie£y, isolated acini were incubated with 2 WM fura-
2/AM at 37‡C in 10 ml PSS for 30 min, washed with
30 ml PSS and resuspended in 10 ml fresh PSS. All
experiments were performed using a dual wavelength
(340/380 nm emitted at 505 nm) modular £uorometry
system (SPEX Fluorolog 2) coupled to a Nikon Dia-
phot inverted microscope (U40). Acini were placed
on a zero cover glass, mounted in a closed chamber
and superfused by an eight-chambered reservoir
(1 ml/min). A £uorescence ratio was converted to
[Ca2]i according to in vitro calibration with an ex-
ternal standard (Calcium kit II, Molecular Probes,
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Eugene, OR, USA) and 50 WM fura-2 potassium
salt.
2.3. IP
Acinar cells (2U106) in 1 ml PSS were incubated
with reagents for 20 min at 37‡C. The incubation was
terminated with 1 ml chilled 8 mM HEPES (bu¡er
A), containing (in mM) 1 sodium orthovanadate, 0.5
NaH2PO4, 109.5 NaCl, 4.7 KCl and 1.13 MgCl2.
The suspension was immediately centrifuged (10 000
rpm) for 15 s at 4‡C. The supernatant was discarded
and the resultant pellet was resuspended in chilled
lysis bu¡er (bu¡er B; pH 7.4), containing (in mM)
25 L-glycerophosphate, 0.2 sodium orthovanadate,
1 phenylmethylsulfonyl £uoride (PMSF), 5 EDTA,
1 dithiothreitol (DTT), 150 NaCl, 50 tris(hydroxy-
methyl)aminoethane (Tris), 25 sodium £uoride, 0.2%
Triton X-100, 10 Wg/ml leupeptin and 0.05 trypsin
inhibitor units (TIU)/ml aprotinin. Each suspension
was sonicated, vortexed for 30 s and centrifuged
(10 000 rpm) for 10 min at 4‡C. The suspension
was diluted with bu¡er B to 1 mg protein/ml. Protein
concentrations were measured using the Bio-Rad
protein assay reagent kit (Hercules, CA, USA). 500
Wl samples were incubated with the anti-CaMKIV
monoclonal antibody (10 Wg/ml) overnight at 4‡C
and with 50 Wl of protein G-Sepharose (Pharmacia
Biotech, Uppsala, Sweden) for 2 h at 4‡C. The im-
munoprecipitates were washed three times with 100
mM Tris^HCl bu¡er, pH 7.5, containing 150 mM
NaCl and 1.5 ml/l Tween 20, and then analyzed by
sodium dodecyl sulfate (SDS)^PAGE and Western
blotting.
2.4. Western IB
Acinar cells (2U106) in 0.5 ml PSS were incubated
with secretagogues for the indicated periods. The in-
cubation was terminated with bu¡er A. The suspen-
sion was immediately centrifuged (10 000 rpm) for 15
s at 4‡C. The supernatant was discarded and the
resultant pellet was resuspended in 150 ml chilled
lysis bu¡er, which consists of (in mM) 66.7 L-glycer-
ophosphate, 1 sodium orthovanadate, 1 PMSF, 1.5
EGTA, 1 DTT, 1% Triton X-100, 10 Wg/ml leupeptin
and 0.05 TIU/ml aprotinin (bu¡er C; pH 7.4). Each
suspension was sonicated, vortexed for 30 s at 4‡C
and centrifuged at 10 000 rpm for 10 min. The super-
natant (20^25 Wl ; 30^37.5 Wg protein) was mixed
with 2.5 ml of 100% L-mercaptoethanol and 12.5
ml of Laemmli bu¡er (bu¡er D), containing 62.5
mM Tris-base, 2.3% SDS, 7.5% glycerol and 0.1%
bromophenol blue. The solution was heated at
95‡C for 5 min, separated by SDS^PAGE on 15%
polyacrylamide gels and electrophoretically trans-
ferred to a nitrocellulose membrane (NM; Bio-
Rad) for 1 h at 4‡C. IB was performed using either
an anti-CaMKIV monoclonal antibody (4 Wg/ml),
anti-CaMKII monoclonal antibody (2 Wg/ml) or
anti-CaMKIV polyclonal antibody (1 Wg/ml). The
membrane was then incubated with the peroxidase
(0.3 Wg/ml)-conjugated goat anti-mouse IgG (1:5000
dilution). The blots were developed and visualized
with a chemiluminescent horseradish peroxidase sub-
strate (ECL, Amersham, Arlington Heights, IL,
USA).
2.5. Measurement of Ca2+/CaMK activities
For measurement of CaMK activities, the REA
was performed, using a CaMKII assay kit with
changes in CaMK substrates (UBI). Aliquots (0.5
ml) of the acinar cell suspension (2U106 cells/PSS)
were incubated with reagents for 20 min at 37‡C. The
incubation was terminated with 1 ml chilled PSS, and
the aliquots were immediately centrifuged (10 000
rpm) for 50 s in a microfuge. The supernatant was
removed and the resultant pellet was resuspended in
50 Wl chilled 50 mM HEPES bu¡er (pH 7.4), con-
taining 50 mM L-glycerophosphate, 25 mM NaF, 1%
Triton X-100, 150 mM NaCl, 20 mM EGTA, 15 mM
MgCl2, 1 mM DTT, 25 Wg/ml leupeptin and 25 Wg/ml
aprotinin (extraction bu¡er). Each suspension (30
samples) was immediately frozen in liquid nitrogen
and stored at 370‡C overnight. The sonicates were
vortexed and allowed to settle for 10 min at 4‡C,
then centrifuged (10 000 rpm) for 15 min at 4‡C.
Each 10 Wl sample of the supernatant (V50 Wg pro-
tein) was combined with 20 Wl of substrate solution,
which contained 10 Wg peptide Q (CaMKIV sub-
strate), 1 WM protein kinase A inhibitor peptide,
1 WM protein kinase C (PKC) inhibitor peptide, 20
mM MOPS, pH 7.2, 25 mM L-glycerol phosphate,
1 mM sodium orthovanadate, 1 mM DTT and 1 mM
CaCl2 (assay dilution bu¡er; ADB). In separate ex-
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periments, autocamtide II (10 Wg) and MLCK sub-
strate (10 Wg) were used as substrates for CaMKII
and MLCK, respectively. For the control reactions,
10 Wl of the supernatant from corresponding cell ex-
tracts was combined with 20 Wl ADB without peptide
Q, autocamtide II or MLCK substrate. All proce-
dures were performed at 4‡C. Aliquots (10 Wl each)
of [Q-32P]ATP (1 WCi) (Amersham) dissolved in ADB,
500 WM ATP and 75 mM MgCl2 were added to each
sample at 30‡C. The ¢nal volume per incubation was
40 Wl. The ¢nal incubation bu¡er contained 5 mM
EGTA and 0.75 mM CaCl2 (Ca2-free). After incu-
bation for 10 min at 30‡C, a 25 Wl aliquot was spot-
ted onto p81 phosphocellulose papers, which were
mounted on a piece of aluminum foil. Each disc
was placed in a glass scintillation vial containing 15
ml of 0.75% phosphoric acid. After 30 min mixing at
room temperature, the washing reagent was decant-
ed. Each disc was then mixed with 10 ml of 0.75%
phosphoric acid, followed by 10 ml acetone, for
10 min, respectively, at room temperature. Each re-
agent was decanted after each washing. Finally, 10
ml of scintillant (Cytoscint, ICN, Costa Mesa, CA,
USA) was added and the radioactivity remaining on
each binding paper was counted in a liquid scintilla-
tion counter. Non-speci¢c binding of [Q-32P]ATP to
the binding paper without substrates (peptide Q, au-
tocamtide II or MLCK substrate) was subtracted
from each control sample that included the substrate.
Non-speci¢c binding of [Q-32P]ATP was V30% of
total binding. It was V6% when substrates, but
not cell extracts, were added. Ca2-independent
CaMK activities were expressed as pmol/min/mg
protein.
3. Results
3.1. Expression of CaMKII and CaMKIV in rat
pancreatic acini
IP and IB studies utilizing CaMKII and CaMKIV
monoclonal antibodies in acinar cell lysates showed
that rat pancreatic acini expressed both CaMKII and
CaMKIV at the location of 60 kDa (Fig. 1). The
immunodetectable CaMKIV band required IP and
IB, whereas CaMKII was immunodetected by IB
alone. A polyclonal antibody of CaMKIV was capa-
ble of detecting several CaMKs by IB. Probing West-
ern blot with the polyclonal antibody immunode-
tected four major proteins ranging from 40 kDa to
60 kDa (Fig. 2). Among these, p50 which is yet to be
identi¢ed (third band from the top), is quantitatively
close to p51 CaMK present in rat pancreatic acini;
p51 CaMK phosphorylates p29 ribosomal protein S6
[21,22]. The upper band (p60) may correspond to
CaMKIV or CaMKII, as A431 cell lysates expressed
a single band at the same location. The CaMKIV
polyclonal antibody may recognize both CaMKII
and CaMKIV because of their structural similarities.
Note that each ¢gure (Figs. 1^9) presented in this
study and statistical analyses were prepared from
data conducted on the same series of experiments.
3.2. Phosphotransferase activities of CaMKII,
CaMKIV and MLCK
The objective of this study was to identify and
characterize the functional roles of CaMK in medi-
ating pancreatic enzyme secretion. This is because
Fig. 1. IP and IB of CaMKII and CaMKIV in rat pancreatic
acinar cell lysates. Isolated pancreatic acini were treated with or
without CCK-8 for 20 min at 37‡C. Proteins from Triton X-
100-soluble fractions (10 000 rpm supernatant of cell sonicates)
were immunoprecipitated with monoclonal anti-CaMKIV anti-
body (immunogen: CaMKIV N-terminus), analyzed by SDS^
PAGE and immunoblotted with monoclonal anti-CaMKIV
antibody (upper panel). Cell lysates were resolved in SDS^
PAGE gels and transferred to nitrocellulose membrane electro-
phoretically. Membrane was blotted with monoclonal anti-
CaMKII antibody, whose immunogen is the regulatory domain
of CaMKII (lower panel). Similar results were observed in sev-
en experiments. Positive control: Jurkat cell lysates (not
shown). Abbreviations: US, unstimulated cells ; IP, immunopre-
cipitation; IB, immunoblotting.
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our preliminary data showed that the speci¢c CaM-
KII inhibitor KN-62 [8] did not inhibit amylase se-
cretion elicited by Ca2-mobilizing secretagogues [9].
In separate studies, we showed that KN-62 signi¢-
cantly inhibited acid secretion from parietal cells [10].
These results suggest the possibility that other
CaMK(s) may be involved in stimulus^secretion cou-
pling of rat pancreatic acinar cells. Peptide Q
(KSDGGVKKRKSSSS), a sequence from CaKIIQ
(345^358), is speci¢c for CaMKIV (Km = 8 WM)
and is a poor substrate for CaMKII [23]. Autocam-
tide II (KKALRRQETVDAL), a sequence derived
from CaMKII autophosphorylation site RQETVD
plus basic residues to facilitate phosphocellulose
binding, is a highly selective CaMKII substrate
(Km = 2 WM) [24]. Substrates for CaMKII require
the consensus sequence RXXS(T) and underlines
mean phosphorylated amino acids. MLCK substrate
(KKRAARATSNVFA-NH2), a sequence from
chicken gizzard smooth muscle myosin P-light chain
(MLC11^23) with Pro to Ala-14 and Gln to Ala-15,
is speci¢c for MLCK (Km = 7.5^8.6 WM) [25,26].
Basal phosphotransferase activities (20 min incuba-
tion without stimulation) of CaMK in rat pancreatic
acini were as follows (pmol/min/mg protein):
30.7 þ 3.2 (peptide Q, n = 12), 20.2 þ 2.0 (autocamtide
II, n = 18) and 4.4 þ 0.7 (MLCK substrate, n = 18).
These basal activities were 7^123-fold higher than
those of Src/protein tyrosine kinase activities (0.25^
0.63 pmol/min/mg protein) [27], suggesting a quanti-
tative predominance of Ser/Thr kinases in pancreatic
acini as well as other eukaryotic cells. Stimulation of
intact acini with CCK-8, a high-a⁄nity CCK-A re-
ceptor agonist CCK-OPE and CCh for 20 min dose-
dependently increased the phosphotransferase activ-
ity of CaMKIV (Fig. 3A). As shown in Fig. 3B,C,
these secretagogues also increased phosphotransfer-
Fig. 3. Phosphotransferase activities of CaMK using di¡erent substrates. Acini were treated with or without CCK-8, CCK-OPE and
CCh for 20 min at 37‡C and CaMK phosphotransferase activities of the cell lysates were measured. A: peptide Q (CaMKIV sub-
strate); B: autocamtide II (CaMKII substrate); C: myosin light chain kinase (MLCK) substrate. Insets of B and C are enlarged ¢g-
ures from originals. A, B and C are the mean þ S.E.M. from six, three and three separate experiments, respectively, each performed in
duplicate. *P6 0.05, **P6 0.01, ***P6 0.005 and ****P6 0.001 compared with basal values (US) by two-tailed unpaired t tests.
Fig. 2. Western IB of CaMKIV with polyclonal anti-CaMKIV
antibody. Pancreatic acini were treated with or without CCK-8
or CCh for 20 min at 37‡C. Cell lysates were resolved in 7.5%
SDS^PAGE and transferred to polyvinylidene di£uoride for IB.
The primary CaMKIV polyclonal antibody (immunogen: CaM-
KIV C-terminus) was detected using a goat anti-rabbit IgG
linked to horseradish peroxidase developed with ECL. Four
major bands (p60, p57, p50 and p40) were observed. Positive
control : A431 cell lysates. Similar results were observed in three
experiments.
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ase activities of CaMKII and MLCK. The maximal
activities were however approximately 30% (CaM-
KII) and less than 10% (MLCK) compared with
those occurring in CaMKIV activities. Time course
studies showed that the maximal activity of CaM-
KIV occurred at 20 min following stimulation with
secretagogues accompanied with the ¢rst initial peak
occurring at 3^10 min (Fig. 4A). A similar phenom-
enon was observed with CaMKII activity (Fig. 4B).
3.3. Requirements of calcium on CaMKII and
CaMKIV activities
We next examined whether the phosphotransferase
activities of CaMKII and CaMKIV in pancreatic
acinar lysates are Ca2-dependent or not. This is
because CaMKII causes an autophosphorylation at
Tyr-286 in the regulatory subunit upon binding
Ca2/CaM, leading to the activation of enzyme in a
Ca2-independent manner [28^32]. On the other
hand, CaMKIV does not appear to be signi¢cantly
activated by autophosphorylation. Intact acini were
stimulated with secretagogues for 20 min in the pres-
ence of extracellular Ca2 concentration ([Ca2]o)
and the cell lysates were resuspended with either
the extraction bu¡er ([Ca2]-free) or the assay bu¡er,
which contained 1 mM CaCl2 (see Section 2). Note
that all other experiments except Fig. 5 were per-
formed in the cell lysates suspended in a [Ca2]-free
extraction bu¡er to measure Ca2-independent
CaMK activities. As shown in Fig. 5A, CaMKIV
activities were not reduced, but rather enhanced, by
eliminating [Ca2], whereas elimination of [Ca2] in
the cell lysates resulted in a 70^75% reduction of
CaMKII activities (Fig. 5B). These results suggest
that once CaMKIV is activated, it does not require
[Ca2] for the subsequent substrate phosphorylation.
On the other hand, Ca2-independent activities of
CaMKII were 25^30% of total activities occurring
in the presence of [Ca2]. Distinct characteristics be-
tween CaMKII and CaMKIV were also observed in
intact cells. Fig. 6 depicts the e¡ects of [Ca2]o on
CaMK activities in intact acini. Elimination of
[Ca2]o (zero CaCl2 plus 1 mM EGTA in PSS) did
not signi¢cantly alter the CaMKIV activity (only 4^
13% inhibition), whereas this maneuver signi¢cantly
reduced the CaMKII activity. Thus Ca2 in£ux from
the extracellular space appears to be not fully re-
quired for the activation of CaMKIV. Intracellular
Ca2 release from the stores elicited by CCK-8 or
Fig. 5. E¡ects of Ca2 on CaMK activities. Acini were treated
with or without CCK-8, CCK-OPE and CCh for 20 min at
37‡C and phosphotransferase activities of CaMK were mea-
sured in the presence (1 mM CaCl2) or the absence (5 mM
EGTA plus 0.75 mM CaCl2, see Section 2) of [Ca2]. A: pep-
tide Q ; B: autocamtide II. A and B are the mean þ S.E.M. from
two (n = 7 for each column) and two (n = 5 for each column)
separate experiments, respectively. *P6 0.05 and ***P6 0.005
compared with 1 mM [Ca2] in each stimulation (unpaired
t tests).
Fig. 4. Time course studies of CaMK activities using di¡erent
substrates. Acini were treated with or without CCK-8 (10 nM),
CCK-OPE (1 WM) and CCh (100 WM) for indicated time peri-
ods at 37‡C and CaMK phosphotransferase activities of the cell
lysates were measured. Note that 100 pM CCK-8 was used for
CaMKII activities in this ¢gure and Figs. 5 and 6, because this
concentration caused a maximal response (see Fig. 3B). A: pep-
tide Q ; B: autocamtide II. An inset of B is the enlarged ¢gure
from the original. A and B are the mean þ S.E.M. from
seven and eight separate experiments, respectively, each per-
formed in duplicate. *P6 0.05, **P6 0.01, ***P6 0.005 and
****P6 0.001 compared with the zero time by unpaired t tests.
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CCh and intracellular Ca2 oscillations induced by
CCK-OPE may be su⁄cient to activate CaMKIV.
Conversely, Ca2 in£ux was partly (40^50%) re-
quired for the activation of CaMKII.
3.4. E¡ects of CaMK inhibitors on CaMK activities
As the speci¢c inhibitor of CaMKIV is not avail-
able at present, we performed the random screening
of potential inhibitors of CaMKs and MLCK. Pre-
treatment of intact acini with wide spectrum inhibi-
tors of CaMKs and MLCK, K-252a (1 WM) and its
derivative KT5926 (3 WM) [33], for 10 min and the
following stimulation with or without CCh (100 WM)
for 20 min resulted in a signi¢cant inhibition of
CaMKIV activities (Fig. 7). K-252a also signi¢cantly
inhibited basal and CCK-8- or CCK-OPE-stimulated
CaMKIV activities in rat pancreatic acini [34]. The
CaM inhibitor, W-7 (100 WM), reduced CCh-induced
CaMKIV activity (CCh alone: 113.6 þ 19.1 vs.
CCh+W-7: 75.8 þ 8.4 pmol/min/mg protein, n = 10,
P6 0.05 by unpaired t tests). In contrast, the speci¢c
inhibitor of CaMKII, KN-62 [8], had no e¡ect on the
CaMKIV activity even at the maximal dose used (50
Table 1
E¡ects of K252-a and ML-9 on CCK-8-stimulated pancreatic amylase secretion
Control +K-252a (3 WM) +ML-9 (10 WM)
US 10.4 þ 1.7 (10) 13.5 þ 2.2 (8) 18.0 þ 2.1 (4)
CCK-8 10311 M 31.0 þ 4.4 (10) 20.8 þ 2.1 (8)** 43.7 þ 3.2 (4)
10310 M 39.2 þ 2.0 (10) 26.4 þ 1.6 (8)*** 48.2 þ 2.5 (4)
1039 M 30.0 þ 1.9 (10) 21.5 þ 2.2 (7)* 30.3 þ 1.9 (4)
1038 M 19.8 þ 1.1 (10) 21.6 þ 2.5 (8) 21.3 þ 1.3 (4)
Isolated acini were pretreated with or without K-252a and ML-9 for 10 min and further coincubated with or without CCK-8 for 60
min for 37‡C. Data are the mean þ S.E.M. from 2^5 separate experiments expressed in % of total/60 min. Numbers in parentheses in-
dicate the number of determinations. *P6 0.05, **P6 0.01 and ***P6 0.005 compared without K252-a (CCK alone) by two-tailed
unpaired t tests. Abbreviation: US, unstimulated cells.
Fig. 7. E¡ects of CaM and CaMK inhibitors on CaMK activ-
ities. Acini were pretreated with or without various inhibitors
for 10 min and further coincubated with or without CCh for 20
min at 37‡C, and phosphotransferase activities of CaMKIV
(peptide Q as a substrate) of the cell lysates were measured.
Data are the mean þ S.E.M. from two separate experiments
(n = 5 for each column). *P6 0.05, **P6 0.01, ***P6 0.005
and ****P6 0.001 compared without inhibitors (control) by un-
paired t tests.
Fig. 6. E¡ects of extracellular Ca2 on CaMK activities. Acini
were treated with or without CCK-8, CCK-OPE and CCh for
20 min at 37‡C in the presence (1.28 mM CaCl2 in PSS) or the
absence (1 mM EGTA plus zero CaCl2 in PSS) of extracellular
Ca2 concentration ([Ca2]o) and CaMK phosphotransferase
activities of the cell lysates were measured. Note that CaMK
activities were measured in the presence of [Ca2]o (intact cells)
and the absence of [Ca2] (cell lysates) in all experiments except
Fig. 5 and this ¢gure. A: peptide Q ; B: autocamtide II. A and
B are the mean þ S.E.M. from two (n = 8 for each column) and
three (n = 12 for each column) separate experiments, respec-
tively. *P6 0.05, ***P6 0.005 and ****P6 0.001 compared
with zero mM [Ca2]o in each stimulation (unpaired t tests).
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WM). Results indicate that K-252a and KT5926 may
be useful as potent inhibitors for CaMKIV.
3.5. E¡ects of the CaM inhibitor W-7 and CaMKII
inhibitor KN-62 on pancreatic enzyme secretion
We next compared the potency of the CaM inhib-
itor W-7 and CaMKII inhibitor KN-62 on pancre-
atic enzyme secretion. Fig. 8A shows that W-7 at 100
WM signi¢cantly inhibited amylase secretion evoked
by CCK-8 (1^100 pM), CCK-OPE (1^1000 nM) or
CCh (1^100 WM). Similar to the e¡ects of KN-62 on
the CaMKIV activity, KN-62 at 50 WM had no e¡ect
on secretion (Fig. 8B), suggesting that CaMKII is
not involved in stimulus^secretion coupling of pan-
creatic acini. This dose of KN-62 in turn signi¢cantly
inhibited acid secretion from rabbit parietal cells,
serving as a positive control [10].
3.6. E¡ects of K-252a on secretagogues-stimulated
Ca2+ spiking and amylase secretion
Fig. 9A shows that K-252a (1 WM), a likely CaM-
KIV inhibitor candidate, did not a¡ect the sustained
[Ca2]i plateau evoked by CCh, suggesting that it
acts on post Ca2 signal events. K-252a at 3 WM
also did not alter Ca2 in£ux elicited by CCK-8
[34]. Alternatively, K-252a inhibited intracellular
Ca2 oscillations induced by CCK-OPE, suggesting
that activated CaMKIV acts as a positive feedback
regulator on intracellular Ca2 oscillations activated
by the high-a⁄nity CCK-A receptor [34]. Activated
PKC, in turn, acts as a negative feedback regulator
on CCK-8 or CCK-OPE-induced Ca2 oscillations
[20,35]. It is also interesting to note that the PTK
inhibitor genistein selectively inhibited Ca2 in£ux
evoked by CCK-8 and CCh, whereas it had no e¡ect
on Ca2 oscillations stimulated by CCK-8, CCK-
OPE and CCh [27,34]. This suggests that PTK pos-
itively mediates extracellular Ca2 in£ux. K-252a (1^
10 WM) signi¢cantly inhibited enzyme secretion
evoked by CCh or CCK-8 (Fig. 9B and Table 1).
Because a supramaximal concentration of CCK-8
caused a reduction of amylase secretion probably
due to negative feedback regulation by PKC
[35,36], K-252a had no e¡ect on the action stimu-
lated by 10 nM CCK-8. K-252a also signi¢cantly
Fig. 9. E¡ects of the CaMK inhibitor K-252a on CCh-evoked
Ca2 spiking and pancreatic amylase secretion. A is a represen-
tative tracing of four determinations. B: Acini were pretreated
with K-252a for 10 min and further coincubated with CCh for
60 min at 37‡C. B is the mean þ S.E.M. from two separate ex-
periments, each performed in duplicate. *P6 0.05, ***P6 0.005
and ****P6 0.001 compared without K-252a (CCh alone) by
unpaired t tests.
Fig. 8. E¡ects of W-7 (CaM inhibitor) and KN-62 (CaMKII in-
hibitor) on secretagogues-stimulated pancreatic amylase secre-
tion. Acini were pretreated with or without W-7 (100 WM, A)
and KN-62 (50 WM, B) for 10 min and further coincubated
with CCK-8, CCK-OPE and CCh for 60 min at 37‡C. A and B
are the mean þ S.E.M. from four and seven separate experi-
ments, respectively, each performed in duplicate. *P6 0.05,
**P6 0.01, ***P6 0.005 and ****P6 0.001 compared with in-
hibitors by unpaired t tests.
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inhibited amylase secretion stimulated with CCK-
OPE ranging from 10 nM to 1 WM [34]. Because
CCK-8 or CCh caused a small but signi¢cant in-
crease in MLCK activities (see Fig. 3C), we exam-
ined the e¡ects of the speci¢c MLCK inhibitor ML-
9. ML-9 (10 WM), however, did not inhibit but en-
hanced amylase secretion elicited by CCK-8 (see Ta-
ble 1), suggesting that MLCK appears to be not in-
volved in pancreatic enzyme secretion.
We ¢nally performed pharmacological screenings
of CaMK inhibitors, which may be available for
CaMKIV inhibitors (Table 2). A fungal metabolite
ophiobolin A (Helminthosporium maydis) is a cell-
permeable antagonist of CaM and inhibits the acti-
vation of Ca2/CaM phosphodiesterase (IC50 = 9
WM) [37]. This compound is, however, not useful at
least in rat pancreatic acini, because 3 and 10 WM
ophiobolin A with and without CCh toxically se-
creted amylase with concomitant decreases in cellular
amylase (86^95% of total/60 min). KN-93 is a potent
inhibitor of CaMKII (IC50 = 370 nM) [38]. However,
1 and 3 WM KN-93 did not inhibit amylase secretion
induced by 0.1^100 WM CCh. These concentrations
were in turn su⁄cient to inhibit the CCh-induced
parietal cell secretion [38]. KT5926 (1^10 WM), an
analogue of K-252a, signi¢cantly inhibited pancreatic
secretion stimulated by CCh (0.1^300 WM), a manner
similar to that of K-252a (not shown). Therefore, K-
252a and KT5926 seem to be useful as CaMKIV
antagonists at present, though they also act on
MLCK [33]. Because the CaMKII inhibitor KN-62
also inhibits CaMKIII and CaMKV activities and
because K-252a does not a¡ect CaMKIII activity
[39], it appears that, in addition to CaMKII, CaM-
KIII and CaMKV may not be involved in pancreatic
acinar stimulus^secretion coupling.
4. Discussion
Several previous reports using di¡erent approaches
indicated that CaM, Ca2/CaMKs and Ca2/CaM-
dependent protein phosphatases (types 1, 2A and 2B)
are involved in stimulus^secretion coupling of mam-
malian pancreatic acinar cells [11^17,21,22,40^43].
Regarding CaMKs in rat pancreatic acini, a single
component of 51 kDa CaMK, which phosphorylates
the ribosomal S6 protein, was puri¢ed using hydro-
phobic chromatography followed by gel ¢ltration
and a⁄nity chromatography [21,22]. A 92 kDa cyto-
solic protein was greatly increased by Ca2/CaM in
rat pancreatic acini, whereas phosphatidylserine-de-
pendent kinase activity most heavily phosphorylated
proteins of 62 kDa and 40 kDa [40]. CaMKIII
(MW: 95^103 kDa), which only phosphorylates the
endogenous 100 kDa protein identi¢ed as EF-2 that
catalyzes the translocation of peptidyl-tRNA on the
ribosome, was puri¢ed from the cytosol fraction of
the rat pancreas [44,45]. Intracellular Ca2 inhibits
protein synthesis via CaMKIII-catalyzed phosphory-
lation of EF-2 [45]. Thus it appears that several types
of CaMK exist in pancreatic acini and function in
exocytosis, cell di¡erentiation, and cell growth and
proliferation. However, the type of CaMK, which is
involved in pancreatic enzyme secretion, is unclear at
present. Among these, we ¢rst expected that the mul-
tifunctional CaMKII is an important mediator for
pancreatic signal transduction and exocytosis. This
was because CCK and CCh, well known Ca2-mobi-
lizing reagents that stimulate pancreatic amylase se-
cretion, were capable of stimulating CaMKII activity
[12]. Our preliminary data, however, showed that the
speci¢c CaMKII inhibitor KN-62, which signi¢-
cantly inhibited CCh-induced parietal cell acid secre-
tion, had no e¡ect on CCK- and CCh-evoked pan-
creatic enzyme secretion [8^10]. Therefore, we aimed
to identify and characterize the type of CaMK on
pancreatic acinar stimulus^secretion coupling.
IP and Western IB studies using monoclonal anti-
bodies of CaMKII and CaMKIV showed that rat
Table 2
E¡ects of ophiobolin A and KN-93 on CCh-stimulated pancre-
atic amylase secretion
Control +Ophiobolin A +KN-93
3 WM 10 WM 1 WM3 WM
US 8.8 þ 0.8 87.2 93.2 9.4 8.5 þ 0.3
CCh 1037 M 19.0 þ 1.1 88.0 94.6 16.5 18.3 þ 0.4
1036 M 33.6 þ 1.4 86.3 93.5 34.2 32.3 þ 0.7
1035 M 34.9 þ 1.3 89.3 93.7 33.2 31.4 þ 1.3
1034 M 26.6 þ 1.2 88.1 93.5 28.0 25.5 þ 0.7
Isolated acini were pretreated with or without ophiobolin A
and KN-93 for 10 min and further coincubated with or without
CCh for 60 min at 37‡C. Data are the mean þ S.E.M. from
three separate experiments (n = 4^6) expressed in % of total/60
min. No S.E.M. denotes two determinations.
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pancreatic acini expressed both CaMKII and CaM-
KIV. However, Ca2-independent phosphotransfer-
ase activity of CaMKIV was signi¢cantly higher
than that of CaMKII and MLCK in both basal
and stimulated levels. As well as CCK-8 and CCh,
a high-a⁄nity CCK-A receptor agonist CCK-OPE at
1 WM signi¢cantly increased activities of both CaM-
KII and CaMKIV. In this regard, a previous study
showed that, in contrast to CCK-8 and CCh, another
high-a⁄nity CCK-A receptor agonist JMV-180 (1
WM) failed to stimulate CaMKII activity, suggesting
that Ca2 oscillations elicited by JMV-180 are not
enough to switch CaMKII to a maintained Ca2-in-
dependent form in pancreatic acini [12]. This may be
a misinterpretation, as they measured CaMKII activ-
ity after 30 s JMV-180 stimulation. Ca2 oscillations
required approximate 2 min lag time to initiate the
¢rst Ca2 spike [35]. Our study showed that CCK-
OPE stimulated CaMKIV activity at 3 min after cell
stimulation, indicating that intracellular Ca2 oscil-
lations are capable of activating CaMK. It is, how-
ever, true that CCK-OPE-stimulated CaMKIV (or
MLCK) activity was less than that elicited by either
CCK-8 or CCh.
Endogenous CaMKs, which phosphorylated pep-
tide Q and autocamtide II, were apparently distinct
entities because of their di¡erent [Ca2]-dependency.
While the activity of CaMKIV in acinar cell lysates
did not require [Ca2], Ca2-independent activity of
CaMKII only occupied 25^30%. Therefore, CaM-
KIV seems not to require [Ca2] to phosphorylate
peptide Q in cell lysates, once it is activated by
Ca2/CaM in intact cell levels. CaMKIV activities
were rather inhibited by 1 mM [Ca2] and, therefore,
the total activity was less than the Ca2-independent
activity (see Fig. 5A). The mechanism by which
[Ca2] inhibits CaMKIV activity remains unknown.
CaMK IV did not require the presence of [Ca2]o in
intact acini, whereas CaMKII required the presence
of [Ca2]o at least 50% for its full activation. There-
fore, it appears that the initial intracellular Ca2 re-
lease (evoked by CCK-8 and CCh) or sustained in-
tracellular Ca2 oscillations (evoked by CCK-OPE)
may be su⁄cient to activate CaMKIV. Because sus-
tained pancreatic amylase secretion elicited by CCK-
8 and CCh, but not by CCK-OPE, requires the pres-
ence of [Ca2]o [46], CaMKIV may act on the initial
step of pancreatic exocytosis, which is triggered by
the IP3-mediated initial intracellular Ca2 release
coupled to the low-a⁄nity CCK-A receptor and the
muscarinic m3 receptor.
Although the speci¢c inhibitor of CaMKIV is not
available at present, our study suggested that the
wide spectrum inhibitor K-252a is useful as a CaM-
KIV inhibitor. This is because: (1) K-252a abolished
CaMKIV activity in both basal and stimulated
states; (2) K-252a inhibited CCK-8 or CCh-stimu-
lated pancreatic enzyme secretion without a¡ecting
the sustained [Ca2]i plateau; (3) K-252a did not
a¡ect secretagogues-stimulated second messenger lev-
els [34]. Because the CaMKII inhibitor KN-62,
which apparently lacked the ability to inhibit CaM-
KIV activity and pancreatic enzyme secretion evoked
by CCK-8 or CCh, also inhibits CaMKIII and
CaMKV in other cell systems [39], it seems unlikely
that CaMKIII and CaMKV are involved in pancre-
atic exocytosis. CaMKIII, which is highly expressed
in the pancreas, may be involved in Ca2-dependent
protein synthesis [44,45]. While it is clear that CaM-
KII exists in rat pancreatic acini and that CCK-8,
CCK-OPE and CCh increased CaMKII activity, the
functional role of CaMKII is unknown at present. It
has been shown that the K isoform of CaMKIV ex-
pressed using recombinant baculovirus/Sf9 cells pref-
erentially phosphorylated syntide-2 and autocamtide
[47]. Peptide Q, reported to be a speci¢c substrate for
puri¢ed brain CaMKIV [23], was barely phosphory-
lated by expressed CaMKIV. In contrast to our
study, this study [47] also showed that KN-62
strongly inhibited CaMKIV activity. This may sug-
gest that di¡erent subtypes of CaMKIV exist in dif-
ferent tissues. Since the monoclonal antibody of
CAMKI is not available at present, we do not
know whether CaMKI exists and functions in pan-
creatic acini. Furthermore, MLCK appears not to be
involved in pancreatic acinar stimulus^secretion cou-
pling, as the MLCK inhibitor ML-9 did not inhibit
CCK-8-induced secretion.
These things considered together, it is conceivable
that CaMKIV is an important serine/threonine ki-
nase that participates in pancreatic acinar stimulus^
secretion coupling. This is surprising because a pre-
vious study reported that only brain showed signi¢-
cant CaMKIV activity using peptide Q and other tis-
sues including lung, heart, skeletal muscle and
adrenal gland showed very little, if any, activity
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[23]. However, our studies clearly showed that CaM-
KIV exists and functions in pancreatic acinar stim-
ulus^secretion coupling. CaMKIV was initially
named CaMK-Gr, as it is enriched in cerebellar
granule cells [48,49]. The presence of extended se-
quences enriched in glutamate residues may in£uence
the subcellular distribution of this kinase [48]. As
pancreatic acini possess abundant zymogen granules,
there is a possibility that CaMKIV may be located in
these areas. CaMKIV was ¢rst demonstrated in
mouse brain by cDNA cloning and its characteristics
from rat brain have been extensively studied [48^51].
CaMKIV is thought to play a pivotal role in Ca2-
mediated neuronal communication [48^51]. Our
study further suggested that CaMKIV functions in
Ca2-mediated pancreatic exocytosis.
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